A critical discovery in cancer research is emerging with the use of mini-antibodies to reactivate mutated p53. This crucial cancer inhibitor protein is frequently disabled in various forms of malignancies, causing https://gatherbookmarks.com/story22953799/nanobodies-revive-the-p53-protein-a-promising-pathway-for-cancer-therapy